PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Recruiting
- Conditions
- Pancreas CancerPancreas Adenocarcinoma
- Registration Number
- NCT04099134
- Lead Sponsor
- University of Ulm
- Brief Summary
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
- Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
- Age =>18 years
- written informed consent
Exclusion Criteria
- papillary cancer
- neuroendocrine pancreatic tumors
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method General assessment of applied therapy modalities in pancreatic cancer First diagnose to death or end of surveillance (5 years after curative resection) Quality of life in pancreatic cancer patients First diagnose to death or end of surveillance (5 years after curative resection) EORTC QLQ c30 and PAN 26
- Secondary Outcome Measures
Name Time Method Assessment of tumor surveillance in pancreatic cancer patients First diagnose to death or end of surveillance (5 years after curative resection) General epidemiologic assessment First diagnose to death or end of surveillance (5 years after curative resection) Epidemiologic questionaire
Evaluation of predictive and prognostic markers First diagnose to death or end of surveillance (5 years after curative resection)
Trial Locations
- Locations (1)
Universitätsklinikum Ulm
🇩🇪Ulm, Germany